Final Guidance: Assurance Cases, But Not Always Clinicals, For Infusion Pumps
This article was originally published in The Gray Sheet
Executive Summary
In response to a growing number of adverse events, FDA has asked infusion pump manufacturers to submit safety assurance cases to help understand the safety profile of their device when submitting a 510(K). But a final guidance appears to soften expectations that clinical studies always be performed to support clearance.